<> Metropolis Healthcare Share Price Today: Live Metropolis Healthcare Share Price NSE/BSE | 5paisa
METROPOLIS

Metropolis Healthcare Share PriceMetropolis Healthcare

₹1337.95
20.6 (1.56%)
As on 01 February, 2023 | 05:36 BSE: 542650 NSE: METROPOLIS

Metropolis Healthcare Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Metropolis Healthcare

Start SIP

Metropolis Healthcare Share Price

  • Over 1 Month 0.79%
  • Over 3 Month -20.92%
  • Over 6 Month -15.23%
  • Over 1 Year -46.76%

Metropolis Healthcare Key Statistics

P/E Ratio 44.3
PEG Ratio -1.1
Market Cap Cr 6,852
Price to Book Ratio 7.7
EPS 35.3
Dividend 0.6
Relative Strength Index 49.14
Money Flow Index 52.25
MACD Signal -14.18
Average True Range 37.58

Metropolis Healthcare Investment Rating

  • Master Rating:
  • Metropolis Healthcare has an operating revenue of Rs. 1,179.16 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of 24% is great, ROE of 24% is exceptional. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 34 which is a POOR score indicating inconsistency in earnings, a RS Rating of 6 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 146 indicates it belongs to a poor industry group of Medical-Services and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Metropolis Healthcare Financials
IndicatorSep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 280257218
Operating Expenses Qtr Cr 205196172
Operating Profit Qtr Cr 756146
Depreciation Qtr Cr 202012
Interest Qtr Cr 785
Tax Qtr Cr 13710
Net Profit Qtr Cr 382863

Metropolis Healthcare Technicals

EMA & SMA

Current Price
₹1337.95
20.6 (1.56%)
  • Bullish Moving Average
  • ___
  • 5
  • Bearish Moving Average
  • ___
  • 11
  • 20 Day
  • 1340.59
  • 50 Day
  • 1379.76
  • 100 Day
  • 1447.25
  • 200 Day
  • 1623.6
  • 20 Day
  • 1349.16
  • 50 Day
  • 1370.22
  • 100 Day
  • 1456.69
  • 200 Day
  • 1561.08

Metropolis Healthcare Resistance and Support

PIVOT
₹1315.92
Resistance
First Resistance 1332.24
Second Resistance 1347.12
Third Resistance 1363.44
RSI 49.14
MFI 52.25
MACD Single Line -14.18
MACD -15.01
Support
First Resistance 1301.04
Second Resistance 1284.72
Third Resistance 1269.84

Metropolis Healthcare Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 129,509 6,410,696 49.5
Week 135,268 5,647,439 41.75
1 Month 150,293 5,162,561 34.35
6 Month 307,583 9,944,164 32.33

Metropolis Healthcare Result Highlights

Metropolis Healthcare Synopsis

NSE-Medical-Services

Metropolis Healthcar is involved in the business activities of Activities of independent diagnostic/pathological laboratories. Company’s Total Operating Revenue is Rs. 1117.13 Cr. and Equity Capital is Rs. 10.23 Cr. for the Year ended 31/03/2022. Metropolis Healthcare Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L73100MH2000PLC192798 and registration number is 192798.
Market Cap 6,888
Sales 967
Shares in Float 2.56
No of funds 184
Yield 0.59
Book Value 8.35
U/D Vol ratio 0.6
LTDebt / Equity 19
Alpha -0.23
Beta 0.86

Metropolis Healthcare

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 49.76%49.76%49.79%
Mutual Funds 11.79%10.93%12.76%
Insurance Companies 0.94%0.95%1.09%
Foreign Portfolio Investors 23.86%25.57%23.2%
Individual Investors 9.74%9.45%9.26%
Others 3.91%3.34%3.9%

Metropolis Healthcare Management

Name Designation
Dr. Sushil Kanubhai Shah Chairman & Executive Director
Mrs. Ameera Sushil Shah Managing Director
Mr. Hemant Sachdev Non Exe.Non Ind.Director
Mr. Vivek Gambhir Ind. Non-Executive Director
Mr. Sanjay Bhatnagar Ind. Non-Executive Director
Mr. Milind Shripad Sarwate Ind. Non-Executive Director
Ms. Anita Ramachandran Ind. Non-Executive Director

Metropolis Healthcare Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Metropolis Healthcare Corporate Action

Date Purpose Remarks
2022-11-08 Quarterly Results
2022-08-10 Quarterly Results
2022-07-18 Others Inter alia, to consider and approve the revised Audited Standalone Financial results of the Company for the Quarter and Year ended March 31, 2022. per share(400%)Interim Dividend
2022-05-24 Audited Results
2022-02-11 Quarterly Results & Interim Dividend
Date Purpose Remarks
2022-02-22 INTERIM Rs.8.00 per share(400%)Interim Dividend
2021-02-19 INTERIM Rs.8.00 per share(400%)Interim Dividend

Metropolis Healthcare MF Shareholding

Name Amount(cr)
UTI Flexi Cap Fund Regular Plan Growth 24929
Kotak Equity Arbitrage Fund Growth 21566
Aditya Birla Sun Life Flexi Cap Fund Growth 16192
ICICI Prudential Equity Arbitrage Fund Regular Growth 10785
UTI Mastershare Unit Regular Plan Payout Inc Dist cum Cap Wdrl 10659

Metropolis Healthcare FAQs

What is Share Price of Metropolis Healthcare ?

Metropolis Healthcare share price is ₹1337 As on 01 February, 2023 | 05:22

What is the Market Cap of Metropolis Healthcare ?

The Market Cap of Metropolis Healthcare is ₹6851.7 Cr As on 01 February, 2023 | 05:22

What is the P/E ratio of Metropolis Healthcare ?

The P/E ratio of Metropolis Healthcare is 44.3 As on 01 February, 2023 | 05:22

What is the PB ratio of Metropolis Healthcare ?

The PB ratio of Metropolis Healthcare is 7.7 As on 01 February, 2023 | 05:22

Q2FY23